Gao et al. revealed that SIK2 upregulates HIF-1α and promotes glycolysis by activating the PI3K/AKT signaling pathway in ovarian cancer 47, and SIK2-mediated reprogramming of glucose metabolism enhances ovarian cancer cell proliferation and attenuates apoptosis. Here, SIK2 is linked to ovarian carcinoma.